These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22156893)

  • 1. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction.
    Ishihara M; Ikesue H; Matsunaga H; Suemaru K; Kitaichi K; Suetsugu K; Oishi R; Sendo T; Araki H; Itoh Y;
    Clin J Pain; 2012 Jun; 28(5):373-81. PubMed ID: 22156893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients.
    Ishihara M; Iihara H; Okayasu S; Yasuda K; Matsuura K; Suzui M; Itoh Y
    Support Care Cancer; 2010 Dec; 18(12):1531-8. PubMed ID: 19921282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary?
    Kanbayashi Y; Hosokawa T
    J Palliat Med; 2014 Jun; 17(6):683-7. PubMed ID: 24702605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of nausea and vomiting induced by oxycodone administered with prochlorperazine in Japanese cancer patients.
    Yamada T; Kanazawa Y; Aoki Y; Uchida E
    J Nippon Med Sch; 2015; 82(2):100-5. PubMed ID: 25959201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of nausea and vomiting in pain medication for digestive cancer].
    Yamada T; Kanazawa Y; Uchida E; Yokoi K
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1517-21. PubMed ID: 23064063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain.
    Kwong WJ; Diels J; Kavanagh S
    Ann Pharmacother; 2010 Apr; 44(4):630-40. PubMed ID: 20197473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and adequacy of intravenous morphine infusions in children in a paediatric oncology setting.
    Flogegård H; Ljungman G
    Med Pediatr Oncol; 2003 Apr; 40(4):233-8. PubMed ID: 12555251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of medications and resources for treatment of nausea, vomiting, or constipation in hospitalized patients treated with analgesics.
    Suh DC; Kim MS; Chow W; Jang EJ
    Clin J Pain; 2011; 27(6):508-17. PubMed ID: 21368666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of opioids and laxatives, and incidence of constipation, in patients requiring neck-of-femur (NOF) surgery: a pilot study.
    Davies EC; Green CF; Mottram DR; Pirmohamed M
    J Clin Pharm Ther; 2008 Oct; 33(5):561-6. PubMed ID: 18834372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal events after opioid treatment in nonmalignant pain: correlates of occurrence and impact on health-related quality of life.
    Lapane KL; Quilliam BJ; Benson C; Chow W; Kim MS
    J Opioid Manag; 2013; 9(3):205-16. PubMed ID: 23771570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride.
    Etropolski M; Kelly K; Okamoto A; Rauschkolb C
    Adv Ther; 2011 May; 28(5):401-17. PubMed ID: 21494892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprepitant vs. multimodal prophylaxis in the prevention of nausea and vomiting following extended-release epidural morphine.
    Hartrick CT; Tang YS; Hunstad D; Pappas J; Muir K; Pestano C; Silvasi D
    Pain Pract; 2010; 10(3):245-8. PubMed ID: 20230453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
    Tsukuura H; Miyazaki M; Morita T; Sugishita M; Kato H; Murasaki Y; Gyawali B; Kubo Y; Ando M; Kondo M; Yamada K; Hasegawa Y; Ando Y
    Oncologist; 2018 Mar; 23(3):367-374. PubMed ID: 29038236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic metoclopramide is unnecessary with intravenous analgesia in the ED.
    Talbot-Stern J; Paoloni R
    Am J Emerg Med; 2000 Oct; 18(6):653-7. PubMed ID: 11043615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose.
    Wirz S; Nadstawek J; Elsen C; Junker U; Wartenberg HC
    Eur J Cancer Care (Engl); 2012 Jan; 21(1):131-40. PubMed ID: 21880080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians.
    Tsukuura H; Ando Y; Gyawali B; Matsumoto M; Sugishita M; Honda K; Urakawa H; Maeda O; Hasegawa Y
    J Palliat Med; 2015 Nov; 18(11):977-80. PubMed ID: 26509390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects of opioids during short-term administration: effect of age, gender, and race.
    Cepeda MS; Farrar JT; Baumgarten M; Boston R; Carr DB; Strom BL
    Clin Pharmacol Ther; 2003 Aug; 74(2):102-12. PubMed ID: 12891220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.